WHO Director-General Highlights Vital Role of Philanthropy in Global Health at Philanthropy Asia Summit 2025

The landscape of international public health is undergoing a profound transformation, driven increasingly by cross-sector collaborations that bridge the gap between traditional government funding and private sector innovation. This evolving paradigm was the focal point of discussion at the Philanthropy Asia Summit, convened in Singapore from May 5 to May 7, 2025. Against a backdrop of complex geopolitical tensions, economic uncertainties, and persistent health inequities, leaders from the public, private, and philanthropic sectors gathered to chart a resilient course for the future of global medicine.

At the center of these high-level deliberations was Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), who delivered a compelling keynote address emphasizing the indispensable contributions of philanthropic foundations. Dr. Tedros used the international platform to commend the organizing efforts of the Temasek Foundation and the Philanthropy Asia Alliance, while issuing a clarion call for sustained solidarity, strategic co-investment, and unwavering commitment to universal health coverage in an increasingly turbulent world.

The convening in Singapore underscored a broader, systemic shift within international health governance. For decades, the architecture of global health financing relied primarily on bilateral aid from high-income member states and assessed contributions from national governments. However, recurring global crises—ranging from the devastating socioeconomic aftermath of the COVID-19 pandemic to escalating climate-induced health emergencies—have severely strained public treasuries. In response, international health organizations have found it imperative to diversify their funding streams. Philanthropic capital, characterized by its agility, appetite for high-impact innovation, and capacity to take calculated risks, has emerged as a cornerstone in closing the widening financing gaps that threaten to derail global development targets.

Main Facts of the Summit and Strategic Partnerships

The Philanthropy Asia Summit 2025 served as a critical nexus for mobilizing resources and aligning strategic priorities across multiple global health vectors. Throughout the three-day event, delegates focused on core pillars essential for sustainable development, including vaccine equity, robust pandemic preparedness frameworks, the reinforcement of primary health care networks, and the elimination of persistent health disparities.

During his address, Dr. Tedros extended his profound gratitude to the government of Singapore, specifically acknowledging the leadership of His Excellency President Tharman Shanmugaratnam. Singapore’s proactive stance in global health diplomacy and its concrete financial backing have cemented its status as a pivotal node in the international health security network. Notably, Singapore and the Temasek Foundation were among the earliest institutional and philanthropic entities to pledge substantial support to the WHO Investment Round, a novel financing mechanism designed to secure predictable, flexible funding for the organization’s core programmatic work.

"We look forward to your continued leadership and partnership as we work together to realize WHO’s founding vision: the highest attainable standard of health—not as a luxury for some, but a right for all," Dr. Tedros stated during his plenary address. This sentiment resonated deeply with attendees, framing health not merely as a technical challenge of disease eradication, but as a fundamental human right that requires equitable structural architectures to be fully realized.

Chronology and Background of the WHO Investment Round

The integration of philanthropic organizations into the strategic architecture of the WHO represents a deliberate evolution in global health financing. Historically, up to 80 percent of the WHO’s budget has been composed of voluntary contributions tied to specific, donor-designated projects—a funding structure known as earmarked financing. While these funds are vital, their restrictive nature limits the organization’s ability to deploy resources rapidly where they are most needed during unexpected emergencies or to sustain long-term systemic reforms.

To address this structural vulnerability, the WHO launched its landmark Investment Round during the 2024–2025 biennium. The initiative was conceived to broaden the donor base beyond traditional state actors, inviting philanthropic foundations, high-net-worth entities, and the private sector to contribute sustainable, predictable, and ideally unearmarked resources.

The timeline leading up to the Singapore Summit highlights the accelerating momentum of this funding model:

• Late 2023 to Early 2024: The WHO conceptualizes the Investment Round framework to secure predictable funding for its Fourteenth General Programme of Work (GPW 14).
• Mid-2024: Initial high-level consultations take place with philanthropic networks, sovereign wealth funds, and private sector leaders to gauge interest and design accountability mechanisms.
• Late 2024: Early pledges roll in from pioneering nations and philanthropic foundations, including significant commitments from Singapore and the Temasek Foundation.
• May 5–7, 2025: The Philanthropy Asia Summit in Singapore acts as a major catalyst, securing reinforced commitments and cementing operational partnerships between the WHO and Asian philanthropic leaders.
• Looking Ahead (2025–2028): The mobilized funds are systematically deployed to accelerate primary health care strengthening, combat antimicrobial resistance, and enhance global health emergency architectures.

Supporting Data and the Unique Value Proposition of Philanthropy

Quantitative data from global health economists underscores the growing weight of philanthropic capital in international development. While official development assistance (ODA) from governments remains the largest aggregate source of external health financing—totaling tens of billions of dollars annually—philanthropic foundations contribute billions more, often targeting domains that traditional bilateral aid cannot easily reach.

Philanthropy brings distinct advantages to the global health ecosystem:

1. Agility and Speed: Unlike government appropriations, which frequently require protracted legislative approval processes, philanthropic foundations can disburse capital rapidly in response to acute public health emergencies, such as disease outbreaks or natural disasters.
2. Risk Tolerance: Traditional institutional donors are often accountable to taxpayers and face strict fiduciary constraints that discourage speculative investments. Philanthropic organizations, conversely, are uniquely positioned to fund high-risk, high-reward scientific research, technological innovations, and pilot projects that, if successful, can be scaled up globally by multilateral agencies.
3. Advocacy and Norm-Setting: Beyond direct financial contributions, philanthropic entities possess formidable convening power. They frequently excel in raising public awareness, shifting political narratives, combating health misinformation, and advocating for progressive policy frameworks that address the social determinants of health.

When these philanthropic investments are harmonized with the work of governments, multilateral bodies like the WHO, and grassroots civil society organizations, they produce a multiplier effect. They amplify state-led initiatives, fill critical resource voids in fragile settings, and accelerate the transition toward resilient, self-reliant national health systems.

Official Responses and Stakeholder Reactions

The reception of Dr. Tedros’s remarks at the Philanthropy Asia Summit was overwhelmingly positive, reflecting a shared consensus among diverse stakeholders regarding the necessity of cross-sector collaboration. Representatives from participating philanthropic alliances underscored their readiness to move beyond transactional grant-making toward deep, strategic co-creation.

Leaders from the Temasek Foundation expressed immense pride in their ongoing partnership with the WHO, noting that sustainable health security in Asia and globally requires systemic investments in institutional capacity, local manufacturing capabilities for medical countermeasures, and workforce training. Similarly, delegates from the Philanthropy Asia Alliance emphasized that the challenges of the 21st century—ranging from pandemic threats driven by zoonotic spillover to the health impacts of climate change—are far too complex for any single sector to tackle in isolation.

Public health analysts observing the summit noted that the deepening ties between the WHO and Asian philanthropy reflect a broader geopolitical rebalancing of global health leadership. As economic dynamism shifts eastward, philanthropic institutions in Asia are stepping into prominent roles, bringing not only financial capital but also context-specific innovations in digital health, community-based care, and universal health coverage models.

Broader Impact and Implications for Global Health Equity

The strategic integration of philanthropy into the WHO’s Fourteenth General Programme of Work carries profound implications for the future of global health governance. At its core, the collaboration seeks to ensure that the benefits of modern medical science and public health interventions are distributed equitably, rather than remaining the exclusive preserve of wealthy populations.

However, international health experts also emphasize the importance of robust governance, transparency, and alignment with national priorities when engaging philanthropic actors. Ensuring that private capital supports country-led national health strategies—rather than fragmenting them through parallel, donor-driven agendas—remains a paramount objective for the WHO and its member states. By maintaining rigorous accountability frameworks, the global health community can harness the energy and resources of philanthropy while safeguarding country ownership and democratic oversight.

As the international community reflects on the outcomes of the Philanthropy Asia Summit 2025, the message is clear: navigating the complex health landscape of the coming decades will demand unprecedented levels of cooperation. By uniting the normative authority and global reach of the World Health Organization with the dynamic resources and innovative spirit of philanthropic partners, the global health community moves incrementally closer to realizing the enduring vision of health as a fundamental human right for all people, everywhere.